The Catholic university of Korea Bucheon St. Mary's hospital
Welcome,         Profile    Billing    Logout  
 8 Trials 
26 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Lee
NCT05509868: Study of PBK_L1704 for the Treatment of Moderate to Severe Acute Pain After Bunionectomy in South Korea

Recruiting
3
225
RoW
PBK_L1704 0.35mg, PBK_L1704 0.5mg, Placebo
Pharmbio Korea Co., Ltd.
Acute Pain
12/22
12/22
STAMP, NCT05529056: Study of Atropine Therapeutic Effect on Myopic Progression

Recruiting
3
472
RoW
Atropine Sulfate 01, LPTAT01, Atropine Sulfate 02, LPTAT02, Atropine Sulfate 03, LPTAT03, Placebo, LPTAT04
LitePharmTech Co., Ltd.
Myopia, Children
06/23
12/23
NCT05128344 / 2021-003015-26: A Study to Evaluate Safety and Efficacy of AMZ002 Treatment, Compared With Vigabatrin in Participants With Infantile Spasms

Withdrawn
3
150
Europe, US, RoW
AMZ002 injectable solution, 0.5mg/mL, Vigabatrin, oral
Amzell
Spasms, Infantile
06/25
12/25
PREVAIL, NCT05202509 / 2021-005092-39: Cardiovascular Outcome Study to Evaluate the Effect of Obicetrapib in Patients With Cardiovascular Disease

Active, not recruiting
3
9541
Europe, Canada, Japan, US, RoW
Obicetrapib, Placebo
NewAmsterdam Pharma, Monash University
Atherosclerotic Cardiovascular Disease
11/26
11/26
MajesTEC-4, NCT05243797 / 2021-002531-27: Phase 3 Study of Teclistamab in Combination With Lenalidomide and Teclistamab Alone Versus Lenalidomide Alone in Participants With Newly Diagnosed Multiple Myeloma as Maintenance Therapy Following Autologous Stem Cell Transplantation

Recruiting
3
1594
Europe, Canada, US, RoW
Teclistamab, JNJ-64007957, Lenalidomide
Stichting European Myeloma Network, Janssen Pharmaceutica
Multiple Myeloma
04/28
04/32
CARTITUDE-6, NCT05257083 / 2021-003284-10: A Study of Daratumumab, Bortezomib, Lenalidomide and Dexamethasone (DVRd) Followed by Ciltacabtagene Autoleucel Versus Daratumumab, Bortezomib, Lenalidomide and Dexamethasone (DVRd) Followed by Autologous Stem Cell Transplant (ASCT) in Participants With Newly Diagnosed Multiple Myeloma

Recruiting
3
750
Europe, Canada, Japan, US, RoW
Daratumumab, Bortezomib, Lenalidomide, Dexamethasone, Cilta-cel, JNJ-68284528, Cyclophosphamide, Fludarabine
Stichting European Myeloma Network, Janssen Research & Development, LLC
Multiple Myeloma
06/33
08/40
JACKPOT8, NCT04105010: Assessing An Oral Janus Kinase Inhibitor, AZD4205 as Monotherapy in Patients Who Have PTCL

Completed
2
171
US, RoW
AZD4205
Dizal Pharmaceuticals
Relapsed or Refractory Peripheral T Cell Lymphoma
10/23
02/24
NCT05733624: Clinical Trial to Evaluate the Safety and Efficacy of SCAI-001 Compared to Restasis

Completed
2
116
RoW
SCAI-001 0.01% eyedrop, Cyclosporine 0.01%, SCAI-001 0.02% eyedrop, Cyclosporine 0.02%, Restasis 0.05% eyedrop, Cyclosporine 0.05%
SCAI Therapeutics
Dry Eye Syndromes
08/23
02/24
PLATINUM, NCT05338619: A Study of Lazertinib as Consolidation Therapy in Patients With Locally Advanced, Unresectable, EGFR-Mutant Non-Small Cell Lung Cancer (Stage III) Following Chemoradiation Therapy

Recruiting
2
77
RoW
Lazertinib, LECLAZA
Sung Yong Lee, Yuhan Corporation
Non-small Cell Lung Cancer Stage III, EGFR Positive Non-small Cell Lung Cancer, Non-squamous Non-small-cell Lung Cancer
03/26
03/26
WU-KONG1, NCT03974022: Assessing an Oral EGFR Inhibitor, Sunvozertinib in Patients Who Have Advanced Non-small Cell Lung Cancer with EGFR or HER2 Mutation

Active, not recruiting
1/2
315
Europe, Canada, Japan, US, RoW
Sunvozertinib, DZD9008
Dizal Pharmaceuticals
Non-Small Cell Lung Cancer
07/24
07/25
NCT04746573: Effect of Natrox Oxygen Wound Therapy on Non-healing Wounds and Implication of Remote Monitoring and Telehealth for Management in the Home.

Completed
N/A
8
US
Natrox Topical Oxygen Therapy
Inotec AMD Limited, Salem VA Medical Center
Non-healing Wounds
05/22
05/22
JS-CT-2024-02, NCT06591221: The Effectiveness of Chuna Maintenance Therapy for Chronic Bothersome Neck Pain

Recruiting
N/A
250
RoW
Chuna Maintenance Therapy
Jaseng Medical Foundation
Neck Pain, Chronic Pain
12/25
12/25
JS-CT-2024-04, NCT06572579: A Pilot Registry for Ultrasound-guided Pharmacopuncture

Recruiting
N/A
50
RoW
Ultrasound-guided pharmacopuncture treatment
Jaseng Medical Foundation
Neck Pain, Back Pain
12/25
12/25
NCT04701684: WE-TRUST (Workflow Optimization to Reduce Time to Endovascular Reperfusion for Ultra-fast Stroke Treatment)

Recruiting
N/A
564
Europe, US, RoW
Direct to Angio Suite (DTAS) Philips' CBCT triage, Conventional CT/MR triage
Philips Clinical & Medical Affairs Global
Stroke, Acute
12/25
12/25
NCT06734858: Pivotal Trial of SAT-014 for Trauma and Stressor-Related Disorder Symptoms

Recruiting
N/A
110
RoW
SAT014, Control
S-Alpha Therapeutics, Inc.
Post-traumatic Stress Disorder, Adjustment Disorders
07/25
10/25
SAT001-KP-003, NCT06742268: Extension Study on Safety and Rebound Effect of SAT-001 for Myopia in Children

Recruiting
N/A
40
RoW
Single vision spectacles
S-Alpha Therapeutics, Inc.
Myopia
10/25
07/26
Kim, Sung-Rae
NCT05743907: Clinical Trial to Evaluate the Efficacy and Safety of DA-2811 When Added to Ongoing Metformin Monotherapy in Patients With Type 2 Diabetes Who Have Inadequate Glycemic Control

Recruiting
4
232
RoW
DA-2811, Forxiga
Dong-A ST Co., Ltd.
Diabetes Mellitus
12/24
12/24
Yoo
STAMP, NCT05529056: Study of Atropine Therapeutic Effect on Myopic Progression

Recruiting
3
472
RoW
Atropine Sulfate 01, LPTAT01, Atropine Sulfate 02, LPTAT02, Atropine Sulfate 03, LPTAT03, Placebo, LPTAT04
LitePharmTech Co., Ltd.
Myopia, Children
06/23
12/23
NCT01522183: Atypical Hemolytic-Uremic Syndrome (aHUS) Registry

Recruiting
N/A
3000
Europe, Canada, US, RoW
Alexion Pharmaceuticals, Inc., Syneos Health
Atypical Hemolytic-Uremic Syndrome
01/31
01/31
NCT06734858: Pivotal Trial of SAT-014 for Trauma and Stressor-Related Disorder Symptoms

Recruiting
N/A
110
RoW
SAT014, Control
S-Alpha Therapeutics, Inc.
Post-traumatic Stress Disorder, Adjustment Disorders
07/25
10/25
Roh, Jiwoong
NCT03611725: Comparison of Success Rate Between Distal Radial Approach and Radial Approach in STEMI

Completed
N/A
352
RoW
Distal radial artery, Radial artery
Wonju Severance Christian Hospital, Hanmi Pharmaceutical co., ltd.
Distal Radial Artery Approach, ST Elevation Myocardial Infarction
03/23
12/23
Ihm, Sang Hyen
DENEX HTN-KORAS, NCT04307836: DENEX, Renal Denervation Therapy, in Patients With Hypertension on no or 1-3 Antihypertensive Medications

Recruiting
N/A
140
RoW
Renal Denervation
Kalos Medical
Hypertension, Vascular Diseases, Cardiovascular Diseases
07/23
04/24
Kim, Yonghyun
FGCL-3019-095, NCT04419558 / 2020-000697-22: Zephyrus II: Efficacy and Safety Study of Pamrevlumab in Participants With Idiopathic Pulmonary Fibrosis (IPF)

Apr 2024 - Sep 2024: Topline data from ZEPHYRUS-2 trial for IPF
Terminated
3
372
Europe, US, RoW
Pamrevlumab, FG-3019, Placebo
FibroGen
Idiopathic Pulmonary Fibrosis
09/23
09/23
NCT04915924: Post Market Surveillance of the HeartMate 3 Left Ventricular Assist System in Korea

Completed
N/A
358
RoW
HeartMate 3™ left ventricular assist system (HM3 LVAS)
Abbott Medical Devices
Advanced Heart Failure
06/24
06/24
Shorten, Meaghan
NCT05292950 / 2022-003467-21: Study of ARO-MUC5AC in Healthy Subjects and Patients With Muco-Obstructive Lung Disease

Terminated
1
78
Europe, RoW
ARO-MUC5AC, Placebo
Arrowhead Pharmaceuticals, Arrowhead Pharmaceuticals, Inc.
Asthma, Chronic Obstructive Pulmonary Disease
11/24
11/24
NCT05276570 / 2022-003466-20: Study of ARO-RAGE in Healthy Subjects and Patients With Inflammatory Lung Disease

Active, not recruiting
1
275
Europe, RoW
ARO-RAGE, Placebo
Arrowhead Pharmaceuticals, Arrowhead Pharmaceuticals, Inc.
Asthma
03/25
03/25

Download Options